Search Results - "Lentz, Samuel"

Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study by LEVENBACK, Charles F, ALI, Shamshad, LEITAO, Mario M, BAKKUM-GAMEZ, Jamie N, ROSSI, Emma C, LENTZ, Samuel S, BURKE, James J, VAN LE, Linda, TRIMBLE, Cornelia L, COLEMAN, Robert L, GOLD, Michael A, FOWLER, Jeffrey M, JUDSON, Patricia L, BELL, Maria C, DE GEEST, Koen, SPIRTOS, Nick M, POTKUL, Ronald K

“…To determine the safety of sentinel lymph node biopsy as a replacement for inguinal femoral lymphadenectomy in selected women with vulvar cancer. Eligible…”
Get full text

HIPEC after neoadjuvant chemotherapy is associated with acceptable toxicity and favorable quality of life in newly diagnosed advanced ovarian cancer patients by Menzies, Anya V., Usher, Erik C., Hsu, Fang-Chi, Levine, Edward A., Lentz, Samuel S., Kelly, Michael G.

“…To evaluate toxicity, quality of life and PFS in patients with advanced ovarian cancer who underwent neoadjuvant chemotherapy (NAC) followed by CRS and HIPEC…”
Get full text

A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study by Rotman, Marvin, Sedlis, Alexander, Piedmonte, Marion R, Bundy, Brian, Lentz, Samuel S, Muderspach, Laila I, Zaino, Richard J

“…To investigate, in a phase III randomized trial, whether postoperative external-beam irradiation to the standard pelvic field improves the recurrence-free…”
Get more information

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer by Pitiyarachchi, Omali, Friedlander, Michael, Java, James J., Chan, John K., Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas J., Monk, Bradley J., Backes, Floor, Secord, Angeles Alvarez, Bonebrake, Albert, Rose, Peter G., Tewari, Krishnansu S., Lentz, Samuel S., Geller, Melissa A., Copeland, Larry J., Mannel, Robert S.

“…Patients with advanced epithelial ovarian cancer (EOC) alive without progression at a landmark time-point of 10 years from diagnosis are likely cured. We…”
Get full text

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173 by Coleman, Robert L, Ali, Shamshad, Levenback, Charles F, Gold, Michael A, Fowler, Jeffrey M, Judson, Patricia L, Bell, Maria C, De Geest, Koen, Spirtos, Nick M, Potkul, Ronald K, Leitao, Mario M, Bakkum-Gamez, Jamie N, Rossi, Emma C, Lentz, Samuel S, Burke, James J, Van Le, Linda, Trimble, Cornelia L

“…Abstract Objective To determine which patients with near midline lesions may safely undergo unilateral groin dissection based on clinical exam and…”
Get full text

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study by Coleman, Robert L, Brady, William E, McMeekin, D. Scott, Rose, Peter G, Soper, John T, Lentz, Samuel S, Hoffman, James S, Shahin, Mark S

“…Abstract Background Nab-paclitaxel is a novel Cremophor®-free nanoparticle of albumin-stabilized paclitaxel, which has favorable efficacy and toxicity…”
Get full text

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study by Fiorica, James V, Brunetto, Virginia L, Hanjani, Parviz, Lentz, Samuel S, Mannel, Robert, Andersen, Willie

“…Objectives. To estimate the objective response rate and toxicity associated with alternating megestrol acetate (MA) and tamoxifen citrate (T) in women with…”
Get full text

Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses by Kelly, Michael G, Winkler, Stuart S, Lentz, Samuel S, Berliner, Steve H, Swain, Melissa F, Skinner, Halcyon G, Schwartz, Gary G

“…Biomarkers that aid in the differential diagnosis of malignant pelvic masses from benign ones prior to surgery are needed in order to triage women with…”
Get full text

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms by Parson, E. Nicole, B.S, Lentz, Samuel, M.D, Russell, Greg, M.S, Shen, Perry, M.D, Levine, Edward A., M.D, Stewart, John H., M.D

“…Abstract Background Few data exist on the treatment of peritoneal surface dissemination (PSD) from ovarian cancer (OC) with hyperthermic intraperitoneal…”
Get full text

Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study by Berek, Jonathan S, Edwards, Robert P, Parker, Lynn P, DeMars, Leslie R, Herzog, Thomas J, Lentz, Samuel S, Morris, Robert T, Akerley, Wallace L, Holloway, Robert W, Method, Michael W, Plaxe, Steven C, Walker, Joan L, Friccius-Quecke, Hilke, Krasner, Carolyn N

“…The aim of this study was to investigate the efficacy and safety of intraperitoneal catumaxomab in heavily pretreated patients with chemotherapy-refractory…”
Get more information

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study by Whitney, Charles W, Brunetto, Virginia L, Zaino, Richard J, Lentz, Samuel S, Sorosky, Joel, Armstrong, Deborah K, Lee, Roger B

“…Objectives. The objectives of this study were to estimate the clinical response rate and toxicity of daily tamoxifen combined with intermittent weekly…”
Get full text

Transvaginal ureteroneocystostomy by Berry, Laurel K., McKenzie, Collin M., Lentz, Samuel S.

“…Ureteral injury is a known complication of gynecologic surgery with potential long-term sequelae. Traditional management of significant ureteral injury…”
Get full text

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study by Sutton, Gregory, Kauderer, James, Carson, Linda F., Lentz, Samuel S., Whitney, Charles W., Gallion, Holly

“…To determine progression-free survival (PFS) and overall survival (OS) in women with completely resected stage I or II carcinosarcoma of the uterus treated…”
Get full text

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q) by Herzog, Thomas J, Sill, Michael W, Walker, Joan L, O'Malley, David, Shahin, Mark, DeGeest, Koen, Weiner, Sheldon A, Mutch, David, DeBernardo, Robert L, Lentz, Samuel S

“…Abstract Objective. To evaluate the efficacy and safety of topotecan in patients with recurrent ovarian, primary peritoneal, and fallopian tube carcinomas…”
Get full text

Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study by GALLION, Holly H, BRUNETTO, Virginia L, CIBULL, Michael, LENTZ, Samuel S, REID, Gary, SOPER, John T, BURGER, Robert A, ANDERSEN, Willie

“…To determine if circadian timed (CT) chemotherapy results in improved response, progression-free survival (PFS), overall survival (OS), and lower toxicity,…”
Get full text

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study by Sutton, Gregory, Brunetto, Virginia L., Kilgore, Larry, Soper, John T., McGehee, Ramon, Olt, George, Lentz, Samuel S., Sorosky, Joel, Hsiu, Jeng-Gwang

“…Objective. The aims of this study were to substantiate the previously reported activity of ifosfamide in patients with advanced, persistent, or recurrent…”
Get full text

A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study by Hoffman, Mark A, Blessing, John A, Lentz, Samuel S

“…To estimate the antitumor efficacy of dolastatin-10 in patients with measurable recurrences of platinum-sensitive ovarian carcinoma and to determine the nature…”
Get full text

Intraperitoneal hyperthermic chemotherapy using carboplatin: A phase I analysis in ovarian carcinoma by Lentz, Samuel S, Miller, Brigitte E, Kucera, Gregory L, Levine, Edward A

“…Abstract Objective Cyclic platinum-based intraperitoneal chemotherapy has proven to be effective after optimal surgical cytoreduction in ovarian carcinoma…”
Get full text

Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study by Montana, G S, Thomas, G M, Moore, D H, Saxer, A, Mangan, C E, Lentz, S S, Averette, H E

“…To determine if patients with carcinoma of the vulva, with N2/N3 lymph nodes, could undergo resection of the lymph nodes and primary tumor following…”
Get more information

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study by Miller, David Scott, Blessing, John A., Lentz, Samuel S., Waggoner, Steven E.

“…Objective. To estimate the antitumor activity of topotecan in women with advanced, persistent, or recurrent endometrial carcinoma previously treated with…”
Get full text